CAS 25541-09-7

lacto-N-fucopentaosa III* de la leche humana

Descripción:

Lacto-N-fucopentaosa III (LNFP III) es un oligosacárido complejo que se encuentra predominantemente en la leche humana. Se clasifica como un oligosacárido de leche humana (HMO) fucosilado y juega un papel significativo en la nutrición y el desarrollo infantil. LNFP III está compuesto por una estructura central de lactosa con residuos adicionales de fucosa y N-acetilglucosamina, lo que contribuye a sus propiedades únicas. Este oligosacárido es conocido por sus efectos prebióticos, promoviendo el crecimiento de bacterias intestinales beneficiosas, lo que puede mejorar el sistema inmunológico del bebé y la salud intestinal en general. Además, se ha demostrado que LNFP III inhibe la adhesión de patógenos al epitelio intestinal, proporcionando así un efecto protector contra infecciones. Su presencia en la leche humana varía entre individuos y puede verse influenciada por la genética materna y factores dietéticos. El número CAS 25541-09-7 identifica específicamente este compuesto, facilitando su estudio en diversos contextos de investigación científica y nutricional. En general, LNFP III ejemplifica la complejidad y la importancia funcional de los HMO en la lactancia humana.

Fórmula: C₃₂H₅₅NO₂₅

InChI: InChI=1/C32H55NO25/c1-8-16(42)20(46)22(48)30(51-8)57-27-15(33-9(2)39)29(54-14(7-38)26(27)56-31-23(49)21(47)18(44)12(5-36)52-31)58-28-19(45)13(6-37)53-32(24(28)50)55-25(11(41)4-35)17(43)10(40)3-34/h3,8,10-32,35-38,40-50H,4-7H2,1-2H3,(H,33,39)

Clave InChI: InChIKey=WMYQZGAEYLPOSX-QKPOUJQKSA-N

SMILES: O([C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](O[C@@H]([C@@H]([C@H](C=O)O)O)[C@@H](CO)O)O[C@H](CO)[C@@H]3O)[C@@H]1NC(C)=O)[C@H]4[C@@H](O)[C@H](O)[C@H](O)[C@H](C)O4

Sinónimos:

• 6-Deoxyhexopyranosyl-(1->3)-[Hexopyranosyl-(1->4)]-2-(Acetylamino)-2-Deoxyhexopyranosyl-(1->3)Hexopyranosyl-(1->4)Hexose
• <span class="text-smallcaps">D</smallcap>-Glucose, O-6-deoxy-α-<smallcap>L</smallcap>-galactopyranosyl-(1→3)-O-[β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-<smallcap>D</smallcap>-glucopyranosyl-(1→3)-O-β-<smallcap>D</span>-galactopyranosyl-(1→4)-
• Glucopyranose, O-6-deoxy-α-<span class="text-smallcaps">L</smallcap>-galactopyranosyl-(1→3)-O-[β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)]-O-2-acetamido-2-deoxy-β-<smallcap>D</smallcap>-glucopyranosyl-(1→3)-O-β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)-, <smallcap>D</span>-
• Lacto-N-fucopentaose III
• Lacto-N-fucopentaose III, Human Milk
• Lacto-N-fucopentoase-3
• Lacto-N-neofucopentaose II
• Le^x penta
• Lnf Iii
• Lnfp Iii
• O-6-Deoxy-α-<span class="text-smallcaps">L</smallcap>-galactopyranosyl-(1→3)-O-[β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-<smallcap>D</smallcap>-glucopyranosyl-(1→3)-O-β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)-<smallcap>D</span>-glucose
• Glucopyranose, O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-, D-
• O-6-Deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose
• D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-
• LACTO-N-FUCOPENTAOSE III-GEL
• BETA-D-GAL-[1->4]-(ALPHA-L-FUC-[1->3])-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-D-GLC
• III3FUC-NLCOSE4
• LNF III-GEL
• LEWIS-X-PENTASACCHARIDE-GEL
• GAL-BETA1,4(FUC-ALPHA1,3)GLCNAC-BETA1,3GAL-BETA1,4GLC
• β-d-gal-(1→4)-[α-l-fuc-(1→3)]-β-d-glcnac-(1→3)-β-d-gal-(1→4)-d-glc
• CD15 ANTIGEN
• N-[2-[3,5-dihydroxy-2-(hydroxymethyl)-6-(1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxyoxan-4-yl]oxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]acetamide
• Lacto-N-fucopentaose III ,95%
• LEX-PENTASACCHARIDE
• LEWIS-X PENTASACCHARIDE
• LEX
• Lex-lactose, Lewis-X pentasaccharide, LNFP III, β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc
• LE(X)-LACTOSE

O-6-Deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose

CAS: 25541-09-7

Fórmula: C₃₂H₅₅NO₂₅

Pureza: ≥95%

Forma y color: Solid

Peso molecular: 853.7708

Ref: IN-DA007MS9

Lacto-N-fucopentaose III

CAS: 25541-09-7

Fórmula: C₃₂H₅₅NO₂₅

Pureza: ≥ 95%

Forma y color: White to almost white lyophilised powder

Peso molecular: 853.77

Ref: 7W-GC2450

Lacto-N-fucopentaose III

CAS: 25541-09-7

Neutral pentasaccharide naturally present in human breast milk

Fórmula: C₃₂H₅₅NO₂₅

Pureza: Min. 95%

Forma y color: White Powder

Peso molecular: 853.77 g/mol

Ref: 3D-OL04212

Lacto-N-fucopentaose III-GEL

CAS: 25541-09-7

Lacto-N-fucopentaose III-GEL is a synthetic monosaccharide that is used as a building block for the synthesis of complex carbohydrates. Lacto-N-fucopentaose III-GEL is synthesized from fructose, which is methylated with chloromethylated N,N'-diacetylchitobiose as the methylating agent and sodium methoxide as the catalyst. The resulting glycoconjugate is then treated with hydrofluoric acid to introduce fluorine atoms into the carbohydrate backbone.

Pureza: Min. 95%

Ref: 3D-OL05682